Brief: Neurizon Therapeutics Says U.S. FDA Lifts Clinical Hold On NUZ-001
06/10/2025 02:44
Oct 6 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX: U.S. FDA LIFTS CLINICAL HOLD ON NUZ-001 Further company coverage: NUZ.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility